drugset / Trial / NCT04949438
A Study to Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy Volunteers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a study to compare AZD4831 pharmacokinetic (PK) parameters between participants with severe renal impairment and matched healthy volunteers following a single dose administration.
Timeline
- Start
- 2022-01-21
- Primary completion
- 2022-03-04
- Completion
- 2022-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitiperstat | Small molecule | — | Oral |